IMNM
Immunome·NASDAQ
--
--(--)
--
--(--)
5.72 / 10
Netural
Analyst consensus is bullish (66.7% Strong Buy, 33.3% Buy) but historical win rates vary (0‑100%). Weighted analyst rating is 3.78, modest. Fund‑flow score is 7.66 with good inflow ratios yet negative trends across all investor sizes.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-04
InstitutionCraig-Hallum
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for IMNM?
- IMNM holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.72/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
